Icahn School of Medicine at Mount Sinai 1470 Madison Avenue 10029 NY
New York U.S.A.
Jean-Frederic Colombel, MD, is the Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and the Leona M. and Harry B. Helmsley Charitable Trust Inflammatory Bowel Disease Research Center at the Icahn School of Medicine at Mount Sinai. Since 1984, his research has focused on IBD, and thanks to the development of multiple local, national, and international collaborations, he has been able to contribute to important advances in the pathophysiology of the disease. He is past president of the GETAID, European Crohn’s and Colitis Organization and past chair of International Organization for Inflammatory Bowel Disease (IOIBD).
Dr. Colombel was awarded the United European Gastroenterology Federation Research Prize in 2009, the Crohn’s and Colitis Foundation Clinical Research Award in 2014, the Sherman Prize in 2018 and the Jacobi Medallion in 2022. One tangible result of Dr. Colombel’s work has been the publication as primary author or co-author of more than 1,070 peer-reviewed papers with an H index of 185.
Calle Madrazo 24
Atic-2 08006 Barcelona
University College Cork
Professor and Chair of Medicine
College of Health and Medicine and
Alimentary Pharmabiotic Centre, Microbiome
Subrata Ghosh is the Chair and Head of Medicine, College of Medicine and Health at University College Cork since March 2021. He is a principal investigator and deputy director at APC Microbiome Ireland. Subrata has recently been awarded the SFI Research professorship.
Subrata did his doctoral research on the immunology of inflammatory bowel disease (IBD) at University of Edinburgh where he was appointed as faculty.
His predominant research interests are precision medicine in IBD, innovative clinical trials, immune cell plasticity, targeted immunotherapies in IBD, interaction of nutrients, microbes and immune system, innate immunity and epidemiology and health care in IBD. His research has been published in New England Journal of Medicine, Lancet, Nature Medicine, Gastroenterology, Gut, American Journal of Pathology and American Journal of Clinical Nutrition. He has delivered over 700 international invited lectures including over 50 named keynote lectures.
Previously he was the inaugural director of the Institute of Translational Medicine, and Professor of Translational Medicine, University of Birmingham between 2016 and 2020. Between 2009 and 2016 he was the Professor and Chairman of Medicine, University of Calgary, and Head of Medicine, Alberta Health Services, Canada. Between 2002 and 2008 he was the Professor and Chair of Gastroenterology at Imperial College London, Hammersmith Hospital.
Subrata Ghosh is a Fellow of the Academy of Medical Sciences UK, and the Canadian Academy of Health Sciences, both highest honours in health sciences in UK and Canada. He is currently the second member from Ireland on the prestigious International Organisation for Study of IBD (IOIBD). He has served on numerous committees, councils, and grant panels regionally, nationally and internationally, and has been chief editor, associate editor and editorial board member of a number of international reputable journals.
University of Melbourne
St. Vincent's Hospital
3065 Fitzroy Melbourne
Emeritus Director, Clinic of internal Medicine and Gastroenterology, Protestant Hospital Kalk, Teaching Hospital of the University of Cologne.
Past president of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Past president of the German Association of Crohn´s disease and ulcerative colitis
Pathogenesis, Diagnosis, Clinical Trials (Principal investigator on several international studies)
Department of Gastroenterology
GR-10676 Athens Greece
Dr Mantzaris has authored and/or co-authored more than 350 manuscripts in peer review national and international medical Journals and medical books, including Guidelines for the diagnosis and treatment of IBD, Dyspepsia and H. pylori infection, Colorectal cancer, Sedation in GI Endoscopy, and the ECCO-EFCCA Patient Guidelines.
He has run as PI a plethora of international and national industry-initiated and researcher-initiated clinical trials.
He was elected President of the Hellenic Gastroenterological Association, the Hellenic IBD Club, and the Hellenic Club for the study of H. pylori infection.
He has served as member and chairman of the ECCO educational Committee and member of the ECCO Governing Board as Educational Officer, member of the United European Gastroenterology (UEG) and the UEG General Assembly, the Nomination Committee, and the Publication Committee of IOIBD, the governing board of the Medical Society of Athens, and Member of the Governing Board of the Hellenic Institute for Pharmaceutical Research and Technology.
For 14 years he was a member of the Examination Committee for the Specialty of Gastroenterology in Greece. He is honorary member of the Hellenic GI Association, the Hellenic IBD Club and the Romanian IBD Club. In addition, he is Fellow of the AGA, International Member of the ACG, member of the IOIBD, the International Coeliac Society, and (in the past) of the BSG, the Hellenic Immunological Association and the Hellenic Association for the Study of Liver Diseases.
He is serving or has served as member of Editorial Boards of the Journals JCC, APT, IBD, GRP, WJG, and Annals of Gastroenterology, and as reviewer in many national and International medical journals. he has organized numerous educational activities, including National and International GI and IBD Congresses, Symposia, Postgraduate Courses, Tutorials, and Webinars. He has served as consultant in numerous national and international advisory boards for the industry.
North Zealand University Hospital
Dpt. Gastroenterology & Hepatology
Dk-3600 Fredrikssund, Copenhagen Denmark
Head & professor of Danish IBD Centre for eHealth & Epidemiology (DEEP), North Zealand University, Copenhagen, Denmark.
- Affiliated with faculty of Medicine, Copenhagen University, Denmark.
- Board member in past, Danish Society og gastroenterolog & Hepatology (DSGH).
- Honourable member & past head of Epidemiology committee of ECCO.
- Pattern recognition of IBD disease course types in epidemiology og EHealth.(phd DMSci).
- Establish the comprehensive e-health clinic and home monitoring of IBD disease courses via APP development of Constant-Care.com.
Oslo University Hospital Ulleval
1519 Moss Norway
D18E7P4 Beacon Consultants Clinic Dublin Ireland
Hospital Clinic Barcelona
Head Inflammatory Disease
Dr. Julian Panes is senior investigator at Institut Investigacions Biomèdiques August Pi i Sunyer, and formerly the head of the IBD Unit at Hospital Clínic de Barcelona for 1996 – 2022.
His research group is focused on the development of new diagnostic tools particularly imaging modalities, the identification of new molecular targets for treatment of inflammatory bowel diseases, and the development of cell therapies.
He has published more than 400 manuscripts in international peer-reviewed journals, has served as a member of the Scientific Committee of the United European Gastroenterology Federation, the Scientific Committee of European Crohn’s and Colitis organization, has been member of the board of International Organization for the study of Inflammatory Bowel Disease (IOIBD), Associate Editor of Gut, and President of ECCO.
University of Liverpool
Institute of Systems, Molecular and Integrative Biology
Liverpool L69 3GE, UK
Emeritus Professor of Medicine, University of Liverpool, UK
Past President British Society of Gastroenterology
Elected fellow UK Academy of Medical Sciences
Epithelial glycobiology, mucins, microbiota, nutrition
Icahn School of Medicin at Mount Sinai
12 Egan Place
07632 2010 NJ Englewood Cliffs U.S.A.
D-65719 Hofheim am Taunus
Dr. Schölmerich was born in Marburg, Germany and educated at the University of Heidelberg ("Physikum" 1971) and the University of Freiburg (MD, 1973). He obtained lecturer in medicine (PhD) at the University of Freiburg (1984), the certification for internal medicine (1985), the certification for gastroenterology (1988) and for "Special intensive care medicine" for internal medicine (1993). He was research fellow (1982, 1985) and visiting professor (1995) at the University of California, San Diego.
From 1991 until 2010 he was Director of the Department for Internal Medicine I (Gastroenterology/Hepatology, Hematology/Oncology, Endocrinology/ Metabolic diseases, Infectious diseases, Rheumatology/Immunology, Intensive Care Medicine) at the University of Regensburg (since 1991). He served as Deputy Medical Director (1992 – 1994) and Medical Director (1996 – 1999) at the University Medical Center of Regensburg. From 2010 -- 2016 he was Medical Director and CEO of the Hospital of Johann Wolfgang Goethe University Frankfurt.
He was elected to the Executive Committee of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD, 1998 – 2001). He served as Deputy Chairman (2001 – 2004) and Chairman of the IOIBD (2004-2007). In 2004 he was elected to the Senate of the Deutsche Forschung Gemeinschaft (DFG) and was Vice president of the DFG from 2005 until 2011.
His research areas are inflammatory bowel disease, the innate immune system and bacterial-epithelial interactions in the intestine, liver cirrhosis and complications, and bile acid metabolism.
Hospital Israelita Albert Einstein
Department of Gastroenterology
01416.001 Sao Paulo
Dr. Flavio Steinwurz, M.D., MACG, received his medical degree in 1980 and completed the residency in 1984 at São Paulo Federal University, São Paulo, Brazil. In 1987 he trained in Gastroenterology, with focus on in Inflammatory Bowel Diseases, at Lenox Hill Hospital, NY, on the service of Dr. Burton I. Korelitz.
In 1988 he returned to Brazil and became an Assistant Professor at Santos School of Medicine and was Board Certified in Gastroenterology by the Brazilian Medical Association (AMB) and the Brazilian Federation of Gastroenterology (FBG).
In 1994 he became a Fellow of the American College of Gastroenterology (ACG) and in 1996 he received, with honour, his Master degree in Gastroenterology by the Brazilian Institute for the Study and Research in Gastroenterology.
MEMBERSHIPS, EXTRA CURRICUALAR ACTIVITIES, AND AWARDS
He’s emeritus president of the Brazilian Association for Crohn’s and Colitis after 16 years as president.
From 2004 to 2010 he was a Governor for the American College of Gastroenterology (ACG) for Brazil and from 2007 to 2010 the Director of Research of the Albert Einstein Jewish Hospital, São Paulo, Brazil.
In 2010 he became a member of the International Organization for the study of Inflammatory Bowel Disease (IOIBD).
He’s also a member of the advisory board and/or reviewer for many scientific journals like the American Journal of Gastroenterology, Digestive Disease and Sciences, Journal of Crohn’s and Colitis, and Clinics.
In 2010, Dr. Steinwurz received the Geraldo Siffert Award for the Best Abstract presented at the Brazilian Week of Gastroenterology.
In 2012 was honoured with the International Leadership Award from the American College of Gastroenterology in Las Vegas-USA. In 2014 was granted with the William D. Carey Award from the American College of Gastroenterology in Philadelphia –USA.
In 2016 was elected secretary general of the Sao Paulo society of Gastroenterology and Nutrition, and Chair of the international relations committee of the Brazilian Federation of Gastroenterology.
He was the recipient of the 2016 Master award from the American College of Gastroenterology and again, elected Governor of the ACG for Brazil.
President of the PANCCO - Pan-American Crohn’s and Colitis Organization, from 2019 to 2022.
He is a board member and reviewer for many high impact publications in the field of IBD.
Nowadays Dr. Steinwurz is taking care of over 3000 patients with IBD in Instituto Steinwurz de Saude do Intestino and Hospital Israelita Albert Einstein in Sao Paulo, and involved in many research projects, including epidemiology, therapeutic, clinical trials, and biomarkers.
Dpt. Internal Medicine I
72076 TUBINGEN Germany
Eduard F. Stange was Professor of Medicine and Chief, Division of Gastroenterology, Department of
Internal Medicine at the University of Lübeck 1992-2000. He became Chief, Department of Internal Medicne I (Gastroenterology, Hepatology and Endocrinology), at the Robert-Bosch-Krankenhaus (RBK), Stuttgart in 2000-2016. Thereafter he was Senior Professor at the Medical Clinic I, University of Tübingen (2016-2020) and currently is Consultant for the Medical Clinic I, University of Tübingen (since 2020).
He was President of the German Society of Coloproctology and Vice President of the German Society of Mucosal Immunology and Microbiome. Also, he is a former secretary of the International Organisation for Inflammatory Bowel Diseases (IOIBD) and past member of Faculty of 1000.
He organized the first German (DGVS) and European (ECCO) guidelines in IBD. He has a special interest in the pathogenesis and therapy of inflammatory bowel diseases and works on the identification of novel targets for treatment. He was member of several pharmaceutical industry advisory boards and has published over 350 peer reviewed articles (PubMed) including original papers and reviews as well as several books on IBD and the microbiome.
Orebro University Hospital
Department of Gastroenterology
SE-701 85 Orebro Sweden
IOIBD Scientific Secretariat
+31 35 5426745
3742 CN Baarn